Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
1.750
-0.010 (-0.57%)
Jun 3, 2026, 3:56 PM EST

Interpace Biosciences Statistics

Total Valuation

IDXG has a market cap or net worth of 48.75 million. The enterprise value is 46.11 million.

Market Cap48.75M
Enterprise Value 46.11M

Important Dates

The next estimated earnings date is Monday, August 10, 2026.

Earnings Date Aug 10, 2026
Ex-Dividend Date n/a

Share Statistics

IDXG has 27.70 million shares outstanding. The number of shares has increased by 28.44% in one year.

Current Share Class 27.70M
Shares Outstanding 27.70M
Shares Change (YoY) +28.44%
Shares Change (QoQ) +0.01%
Owned by Insiders (%) 3.49%
Owned by Institutions (%) 0.52%
Float 3.47M

Valuation Ratios

The trailing PE ratio is 2.02.

PE Ratio 2.02
Forward PE n/a
PS Ratio 1.35
PB Ratio 2.11
P/TBV Ratio 2.11
P/FCF Ratio 10.78
P/OCF Ratio 9.99
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.02, with an EV/FCF ratio of 10.19.

EV / Earnings 1.95
EV / Sales 1.27
EV / EBITDA 9.02
EV / EBIT 11.31
EV / FCF 10.19

Financial Position

The company has a current ratio of 2.51

Current Ratio 2.51
Quick Ratio 0.67
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 45.31

Financial Efficiency

Return on equity (ROE) is 213.88% and return on invested capital (ROIC) is 19.66%.

Return on Equity (ROE) 213.88%
Return on Assets (ROA) 10.64%
Return on Invested Capital (ROIC) 19.66%
Return on Capital Employed (ROCE) 13.85%
Weighted Average Cost of Capital (WACC) 7.82%
Revenue Per Employee 355,343
Profits Per Employee 231,853
Employee Count102
Asset Turnover 1.51
Inventory Turnover n/a

Taxes

Income Tax -20.93M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +125.64% in the last 52 weeks. The beta is 0.65, so IDXG's price volatility has been lower than the market average.

Beta (5Y) 0.65
52-Week Price Change +125.64%
50-Day Moving Average 1.92
200-Day Moving Average 1.36
Relative Strength Index (RSI) 41.80
Average Volume (20 Days) 8,105

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, IDXG had revenue of 36.25 million and earned 23.65 million in profits. Earnings per share was 0.86.

Revenue36.25M
Gross Profit 22.66M
Operating Income 4.08M
Pretax Income 3.14M
Net Income 23.65M
EBITDA 4.51M
EBIT 4.08M
Earnings Per Share (EPS) 0.86
Full Income Statement

Balance Sheet

The company has 2.65 million in cash and n/a in debt, with a net cash position of 2.65 million or 0.10 per share.

Cash & Cash Equivalents 2.65M
Total Debt n/a
Net Cash 2.65M
Net Cash Per Share 0.10
Equity (Book Value) 23.08M
Book Value Per Share 1.01
Working Capital 6.00M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.88 million and capital expenditures -356,000, giving a free cash flow of 4.52 million.

Operating Cash Flow 4.88M
Capital Expenditures -356,000
Depreciation & Amortization 436,250
Net Borrowing -4.40M
Free Cash Flow 4.52M
FCF Per Share 0.16
Full Cash Flow Statement

Margins

Gross margin is 62.53%, with operating and profit margins of 11.25% and 65.25%.

Gross Margin 62.53%
Operating Margin 11.25%
Pretax Margin 8.65%
Profit Margin 65.25%
EBITDA Margin 12.45%
EBIT Margin 11.25%
FCF Margin 12.48%

Dividends & Yields

IDXG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -28.44%
Shareholder Yield -28.44%
Earnings Yield 48.51%
FCF Yield 9.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 15, 2020. It was a reverse split with a ratio of 0.1.

Last Split Date Jan 15, 2020
Split Type Reverse
Split Ratio 0.1

Scores

Altman Z-Score n/a
Piotroski F-Score 4